IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Endra Life Sciences Inc

CUSIP: 29273B112 | 4 institutional holders

Quarters

Q1 2022Q4 2021Q3 2021Q2 2021Q1 2021
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q1 2022

UBS Group AG16,834
0.0% of portfolio›$0
Proequities, Inc.0
0.0% of portfolio›$0
StyleTurnoverLocationFiled
UBS Group AG
16,834$00.0%CoreMediumZurich, Switzerland2022-05-16
Proequities, Inc.
0$00.0%GrowthVery LowBirmingham, AL2022-05-09